Affordable Medicines Europe AISBL

2.8 FTE

Affordable Medicines Europe reported total assets of 796,058 € at the end of the 2024 financial year (annual accounts filed with the NBB on 24 Dec 2025), with 2.8 full-time equivalents.

By total assets for 2024, Affordable Medicines Europe ranks among the 20,000 largest of the 47,112 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0465.125.985 · VAT BE0465125985
1000 Brussels
active in Business and other management consultancy activities (NACE 70200)
operating since 11 Feb 1999 (≈ 27 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Affordable Medicines Europe shows with a free account.

See the score
Profile
AISBL Micro · 2.8 FTE since 1999
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2024

Net result−€1.17m
Equity466,510 €
Cash57,574 €
EBITDA−997,607 €
Total assets796,058 €
Headcount (avg FTE)2.8
The line marks its sector median: 50.8% (7215 companies).

Change 2021 → 2024: Equity -72 % Total assets -57 % Headcount (avg FTE) +47 %

Accounts of the company itself (not consolidated).

The full file covers 6 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Affordable Medicines Europe's annual accounts

20242023202220212020
Net result−€1.17m
Equity466,510 €
Cash57,574 €
EBITDA−997,607 €
Total assets796,058 €

Filed annual accounts

  • Year ended 31 Dec 2024filed on 24 Dec 2025
  • Year ended 31 Dec 2023filed on 13 Aug 2024
  • Year ended 31 Dec 2022filed on 29 Jun 2023
  • Year ended 31 Dec 2021filed on 28 Jul 2022
  • Year ended 31 Dec 2020filed on 24 Jun 2021

Affordable Medicines Europe's financial analysis

Management and control of Affordable Medicines Europe

27 active director(s) in the register.

and 21 more

Affordable Medicines Europe's shareholders and holdings →

Affordable Medicines Europe's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0465.125.985
VAT number
BE0465125985
Peppol
Registered · 0208:0465125985 · as of 10 Nov 2026
Legal form
AISBL
Incorporated
11 Feb 1999
Registered office
1000 Brussels
Size
Micro · 2.8 FTE
Latest accounts
2024 · filed on 24 Dec 2025
Activity
Business and other management consultancy activities (NACE 70200)

Affordable Medicines Europe (AISBL) has been based in Brussels since 1999, active in: business and other management consultancy activities. For 2024, it reports a net loss of €1.17m and equity of 466,510 €; its revenue is not published. With 2.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 58.6%, above the median of its sector (50.8%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Affordable Medicines Europe

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Affordable Medicines Europe

What is the revenue of Affordable Medicines Europe?

Affordable Medicines Europe files its accounts in a format where revenue is optional: it is not published for 2024.

What is the VAT number of Affordable Medicines Europe?

In Belgium, the VAT number is the company number prefixed with BE: BE0465125985 for Affordable Medicines Europe, if the company is VAT-registered. Its company number (CBE) is 0465.125.985.

Where is the registered office of Affordable Medicines Europe?

According to the CBE register, the registered office of Affordable Medicines Europe is in 1000 Brussels.

What is the equity of Affordable Medicines Europe?

At the close of the 2024 financial year, the equity of Affordable Medicines Europe amounts to 466,510 €, a solvency of 58.6% of total assets.

How many people work at Affordable Medicines Europe?

2.8 full-time equivalents on average according to the 2024 social balance sheet.

Who manages Affordable Medicines Europe?

The register lists 27 active mandates at Affordable Medicines Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Affordable Medicines Europe within its sector?

By total assets for 2024, Affordable Medicines Europe ranks among the 20,000 largest of the 47,112 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.

Idonis

The full file of Affordable Medicines Europe

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 09 Jul 2026

No credit card, no commitment.

What each plan unlocks →